| Cassidy B Waterman, CRNA | |
|
1950 E Clark St, Suite G, Pocatello, ID 83201-3314 | |
| (208) 232-7760 | |
| (208) 232-1950 |
| Full Name | Cassidy B Waterman |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 1950 E Clark St, Pocatello, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750691929 | NPI | - | NPPES |
| CD5673 | Other | ID | RR GROUP LEGACY NUMBER |
| P00956855 | Other | INDIVIDUAL RR MEDICARE | |
| 1604930 | Other | ID | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RNA-781 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Portneuf Medical Center | Pocatello, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sei Anesthesia Pllc | 4183849979 | 22 |
| Northstar Anesthesia Of Idaho Pllc | 6204283856 | 31 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.
A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes.
Outpatient healthcare providers inappropriately prescribed antibiotics to 40 percent of patients in a major Veterans Affairs healthcare system, a higher figure than in previous studies examining outpatient antibiotic use, according to a new study appearing in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology published by Elsevier.
Type 2 diabetes and obesity in pregnancy is a daunting duo, according to new research published this month in The Journal of Maternal-Fetal and Neonatal Medicine. The study shows that both conditions independently contribute to higher risks, opening the door to a wide range of pregnancy, delivery and newborn complications.
Interleukin Genetics, Inc. today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredict™ Genetic Risk Test for periodontal disease.
› Verified 2 days ago
| Entity Name | Sei Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750701199 PECOS PAC ID: 4183849979 Enrollment ID: O20140711000736 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.
A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes.
Outpatient healthcare providers inappropriately prescribed antibiotics to 40 percent of patients in a major Veterans Affairs healthcare system, a higher figure than in previous studies examining outpatient antibiotic use, according to a new study appearing in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology published by Elsevier.
Type 2 diabetes and obesity in pregnancy is a daunting duo, according to new research published this month in The Journal of Maternal-Fetal and Neonatal Medicine. The study shows that both conditions independently contribute to higher risks, opening the door to a wide range of pregnancy, delivery and newborn complications.
Interleukin Genetics, Inc. today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredict™ Genetic Risk Test for periodontal disease.
› Verified 2 days ago
| Entity Name | Northstar Anesthesia Of Idaho Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912686882 PECOS PAC ID: 6204283856 Enrollment ID: O20231103002037 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.
A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes.
Outpatient healthcare providers inappropriately prescribed antibiotics to 40 percent of patients in a major Veterans Affairs healthcare system, a higher figure than in previous studies examining outpatient antibiotic use, according to a new study appearing in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology published by Elsevier.
Type 2 diabetes and obesity in pregnancy is a daunting duo, according to new research published this month in The Journal of Maternal-Fetal and Neonatal Medicine. The study shows that both conditions independently contribute to higher risks, opening the door to a wide range of pregnancy, delivery and newborn complications.
Interleukin Genetics, Inc. today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredict™ Genetic Risk Test for periodontal disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cassidy B Waterman, CRNA 777 Hospital Way, Pocatello, ID 83201-5175 Ph: (208) 240-0735 | Cassidy B Waterman, CRNA 1950 E Clark St, Suite G, Pocatello, ID 83201-3314 Ph: (208) 232-7760 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that its pivotal Phase III Metastatic Melanoma Trial has met its goal of 92 patients and is fully enrolled.
A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes.
Outpatient healthcare providers inappropriately prescribed antibiotics to 40 percent of patients in a major Veterans Affairs healthcare system, a higher figure than in previous studies examining outpatient antibiotic use, according to a new study appearing in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology published by Elsevier.
Type 2 diabetes and obesity in pregnancy is a daunting duo, according to new research published this month in The Journal of Maternal-Fetal and Neonatal Medicine. The study shows that both conditions independently contribute to higher risks, opening the door to a wide range of pregnancy, delivery and newborn complications.
Interleukin Genetics, Inc. today announced it has received conditional approval from the New York State Department of Health to offer, process and report the results of the PerioPredict™ Genetic Risk Test for periodontal disease.
› Verified 2 days ago
Mr. Timothy Morgan Naylor, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 285 Vista Dr, Pocatello, ID 83201 Phone: 208-478-1704 | |
Nicholas Stoddard, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-232-7760 Fax: 208-232-1950 | |
Mark Alan Pendleton, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 082-391-0562 Fax: 208-239-3626 | |
Jamie Leigh Cassinat, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-209-1000 | |
Eric Michael Stradley, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 777 Hospital Way, Pocatello, ID 83201 Phone: 208-239-1000 | |
Richard Aaron Marler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 333 N 18th Ave, Bldg A, Pocatello, ID 83201 Phone: 208-233-8880 Fax: 208-232-1950 | |
Mr. Kenneth Michael Knapp, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 333 N 18th Ave Ste A, Pocatello, ID 83201 Phone: 208-232-7760 Fax: 208-232-1950 |